China Blood Collection Market Size & Outlook, 2022-2030

The blood collection market in China is expected to reach a projected revenue of US$ 1,536.0 million by 2030. A compound annual growth rate of 11.2% is expected of China blood collection market from 2023 to 2030.
Revenue, 2022 (US$M)
$656.3
Forecast, 2030 (US$M)
$1,536.0
CAGR, 2023 - 2030
11.2%
Report Coverage
China

China blood collection market highlights

  • The China blood collection market generated a revenue of USD 656.3 million in 2022 and is expected to reach USD 1,536.0 million by 2030.
  • The China market is expected to grow at a CAGR of 11.2% from 2023 to 2030.
  • In terms of segment, venous was the largest revenue generating collection site in 2022.
  • Capillary is the most lucrative collection site segment registering the fastest growth during the forecast period.


Blood collection market data book summary

Market revenue in 2022USD 656.3 million
Market revenue in 2030USD 1,536.0 million
Growth rate11.2% (CAGR from 2022 to 2030)
Largest segmentVenous
Fastest growing segmentCapillary
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationVenous, Capillary
Key market players worldwideAbbott Laboratories, Nipro Corp, BD, Terumo Corp, Medtronic PLC, Qiagen NV, Haemonetics Corp, FL Medical, Greiner Bio-One


Other key industry trends

  • In terms of revenue, China accounted for 6.2% of the global blood collection market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China blood collection market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,536.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Blood Collection Market Companies

Name Profile # Employees HQ Website

China blood collection market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood collection market will help companies and investors design strategic landscapes.


Venous was the largest segment with a revenue share of 83.93% in 2022. Horizon Databook has segmented the China blood collection market based on venous, capillary covering the revenue growth of each sub-segment from 2018 to 2030.


China is expected to witness significant growth during the forecast period, owing to steady economic improvement, greater health awareness, rise in per-capita disposable income, improving healthcare expenditure, and growing prevalence of noncommunicable diseases.

Local presence of leading market players, such as Guangzhou Improve Medical Instruments, Zhejiang Gong dong Medical Technology, Sanli Group, Jiangsu KANGJIAN Medical Apparatus, Chengdu Rich Science Industry, Lingen Precision Medical Products, and Weigao Group, is expected to boost market growth.

In addition, as the country is developing at a rapid pace, various foreign companies such as Greiner, Sekisui Medical, and BD are investing in the country’s blood collection market. Governing authorities, including the State Council, have introduced policies to support the medical equipment industry of China.

Reasons to subscribe to China blood collection market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China blood collection market databook

  • Our clientele includes a mix of blood collection market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China blood collection market, including forecasts for subscribers. This country databook contains high-level insights into China blood collection market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China blood collection market size, by collection site, 2018-2030 (US$M)

China Blood Collection Market Share, 2022 & 2030 (US$M)

China blood collection market size, by collection site, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more